SCHEMBL3597425

SCHEMBL3597425

O=C(Cn1ncc2cccc(C(F)(F)F)c21)NCCNCC1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.43
MITF O75030 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
RECQL P46063 1/20 0.43
MDM2 Q00987 1/20 0.43
CNR2 P34972 2/20 0.38
TSHR P16473 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CNR1 P21554 1/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
HDAC6 Q9UBN7 6/20 0.36
MLYCD O95822 1/20 0.36
CYP1A2 P05177 1/20 0.36
KCNH2 Q12809 1/20 0.36
GRM2 Q14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597424 0.83 TSHR (0.41) RAB9ASMN1; SMN2MAPTTSHRL3MBTL1
SCHEMBL3602594 0.81 TSHR (0.57) ALDH1A1RAB9ASMN1; SMN2LMNAMITF
SCHEMBL3198672 0.74 ATM (0.49) ALDH1A1RAB9ASMN1; SMN2LMNAMITF
SCHEMBL3603706 0.73 KMO (0.46) ALDH1A1RAB9ASMN1; SMN2LMNAMITF
SCHEMBL13115635 0.73 KMO (0.43) ALDH1A1MAPTMDM2KDM4EPOLB
SCHEMBL3203584 0.72 NPSR1 (0.64) ALDH1A1MAPTHTTTSHRALOX15
SCHEMBL3200380 0.72 LMNA (0.45) ALDH1A1RAB9ASMN1; SMN2LMNAMITF
SCHEMBL3193908 0.72 HDAC6 (0.41) ALDH1A1RAB9ASMN1; SMN2LMNAMITF
SCHEMBL3596889 0.71 HTT (0.66) ALDH1A1SMN1; SMN2LMNAMAPTHTT
SCHEMBL3193840 0.71 MAPT (0.44) ALDH1A1RAB9ASMN1; SMN2LMNAMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 ALDH1A1 662/4885RAB9A 602/4885SMN1; SMN2 4228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.